ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $44,000 | -85.5% | 818 | -69.5% | 0.00% | – |
| Q4 2015 | $303,000 | +17.9% | 2,681 | +22.6% | 0.00% | – |
| Q3 2015 | $257,000 | -74.4% | 2,187 | -83.1% | 0.00% | -100.0% |
| Q2 2015 | $1,003,000 | +107.2% | 12,950 | -13.7% | 0.00% | 0.0% |
| Q4 2014 | $484,000 | +644.6% | 15,000 | +312.1% | 0.00% | – |
| Q2 2014 | $65,000 | +8.3% | 3,640 | +21.3% | 0.00% | – |
| Q1 2014 | $60,000 | -40.6% | 3,000 | -50.0% | 0.00% | – |
| Q4 2013 | $101,000 | -4.7% | 6,000 | -40.0% | 0.00% | – |
| Q3 2013 | $106,000 | +89.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2013 | $56,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |